Eton Pharmaceuticals Files 8-K
Ticker: ETON · Form: 8-K · Filed: Mar 14, 2025 · CIK: 1710340
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory-update
TL;DR
Eton Pharma filed an 8-K, likely routine updates, check for details.
AI Summary
Eton Pharmaceuticals, Inc. filed an 8-K on March 14, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about new events, financial figures, or material agreements within the provided text.
Why It Matters
This filing indicates Eton Pharmaceuticals is providing updates to the SEC, which could contain important information for investors regarding the company's operations or financial status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate indication of significant negative events.
Key Players & Entities
- Eton Pharmaceuticals, Inc. (company) — Registrant
- March 14, 2025 (date) — Date of Report
- 21925 W. Field Parkway, Suite 235 (address) — Principal executive offices
- Deer Park, Illinois (location) — Principal executive offices location
- 60010-7208 (zip_code) — Principal executive offices zip code
- (847) 787-7361 (phone_number) — Registrant's telephone number
FAQ
What specific "Other Events" are being reported by Eton Pharmaceuticals in this 8-K?
The provided text for the 8-K filing does not specify the details of the 'Other Events' being reported.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is March 14, 2025.
What is Eton Pharmaceuticals' principal executive office address?
Eton Pharmaceuticals' principal executive office is located at 21925 W. Field Parkway, Suite 235, Deer Park, Illinois 60010-7208.
Under which section of the Securities Exchange Act is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the SIC code for Eton Pharmaceuticals?
The Standard Industrial Classification (SIC) code for Eton Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 14, 2025 regarding Eton Pharmaceuticals, Inc. (ETON).